Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control
Summary: We present a delay differential model with optimal control that describes the interactions of the tumour cells and immune response cells with external therapy. The intracellular delay is incorporated into the model to justify the time required to stimulate the effector cells. The optimal control variables are incorporated to identify the best treatment strategy with minimum side effects by blocking the production of new tumour cells and keeping the number of normal cells above 75\% of its carrying capacity. Existence of the optimal control pair and optimality system are established. Pontryagin's maximum principle is applicable to characterize the optimal controls. The model displays a tumour-free steady state and up to three coexisting steady states. The numerical results show that the optimal treatment strategies reduce the tumour cells load and increase the effector cells after a few days of therapy. The performance of combination therapy protocol of immunochemotherapy is better than the standard protocol of chemotherapy alone.
- Optimal control of tumour-immune model with time-delay and immuno-chemotherapy
- Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control
- Delay dynamics of cancer and immune cell model
- A tumor-immune model with mixed immunotherapy and chemotherapy: qualitative analysis and optimal control
- Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
- A delay differential equation model for tumor growth
- A history of the study of solid tumour growth: the contribution of mathematical modelling
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- A study of differential equation modeling malignant tumor cells in competition with immune system
- A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis
- Delay differential model for tumour–immune dynamics with HIV infection of CD4+T-cells
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- Mathematical Models of Avascular Tumor Growth
- Modeling immunotherapy of the tumor -- immune interaction
- Modelling Aspects of Cancer Growth: Insight from Mathematical and Numerical Analysis and Computational Simulation
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Numerical treatments for Volterra delay integro-differential equations
- On immunotherapies and cancer vaccination protocols: a mathematical modelling approach
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
- On the global dynamics of a model for tumor immunotherapy
- OPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORS
- Qualitative and computational analysis of a mathematical model for tumor-immune interactions
- The dynamics of an optimally controlled tumor model: A case study
- The ecology and evolutionary biology of cancer: a review of mathematical models of necrosis and tumor cell diversity
- The nonnegativity of solutions to delay differential equations
- Editorial: Applications of delay differential equations in biological systems
- Optimal control problems with time delays: two case studies in biomedicine
- A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
- Optimal control of tumour-immune model with time-delay and immuno-chemotherapy
- Combination of virotherapy and chemotherapy with optimal control for combating cancer
- Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach
- The stability analysis of tumor-immune responses to chemotherapy system driven by Gaussian colored noises
- Convergence and global stability analysis of fractional delay block boundary value methods for fractional differential equations with delay
- Noise and delay enhanced stability in tumor-immune responses to chemotherapy system
- A deterministic and stochastic model for the system dynamics of tumor-immune responses to chemotherapy
- Control strategies for a tumor-immune system with impulsive drug delivery under a random environment
- Dynamics of fractional-order delay differential model for tumor-immune system
- A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies
- Optimal control of variable-order fractional model for delay cancer treatments
- Neural network solution of single-delay differential equations
- Dynamics of tumor growth: chemotherapy and integrative oncology
- An optimal control problem of immuno-chemotherapy in presence of gene therapy
- Interaction tumor-immune model with time-delay and immuno-chemotherapy protocol
- On initial value problems of fractal delay equations
- Analysis of tumour-immune evasion with chemo-immuno therapeutic treatment with quadratic optimal control
- Optimal control of a fractional-order model for the HIV/AIDS epidemic
- A new time-delay model for chaotic glucose-insulin regulatory system
- Hopf-bifurcation analysis of a delayed model for the treatment of cancer using virotherapy
- A novel fitted method for a class of singularly perturbed differential-difference equations with small delay exhibiting twin layer or oscillatory behaviour
- Application of the quasilinearization method to approximate non-linear delay differential equations in physical problems
- Optimal control and global stability of the stomach cancer treatment model in the presence of obesity and psychological scare
- Free end-time optimal control problem for cancer chemotherapy
- Analysis of natural Daftardar-Jafari method for fractional delay differential equations
- Stochastic control model for chemotherapy of cancer
- Modeling, analysis, and optimal control of leukemic cell population dynamics under therapy
This page was built for publication: Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2262736)
